aluates Reports

$ 0.0

Automative

Global Enterovirus Vaccine Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-23S9729

Global Enterovirus Vaccine Market Insights Forecast to 2028

BUY CHAPTERS

Global Enterovirus Vaccine Market Research Report 2025

Code: QYRE-Auto-23S9729

Report

July 2025

Pages:78

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

SINOVAC BIOTECH

Sinopharm

Adimmune

Intravacc

Beijing Minhai Biotechnology

Medigen Vaccine Biologics

Shenzhen Neptunus

Shanghai Zerun Biotechnology

Enterovirus Vaccine Market Size

The global market for Enterovirus Vaccine was valued at US$ 362 million in the year 2024 and is projected to reach a revised size of US$ 534 million by 2031, growing at a CAGR of 5.8% during the forecast period.

Enterovirus Vaccine Market

Hand, foot and mouth disease (HFMD) was first reported in New Zealand in 1957 and occurs mostly in young children, with a peak incidence at about 2 years of age. The causative agents of HFMD are picornaviruses, most often of human enterovirus species A, chiefly the Coxsackie A viruses and Enterovirus A71 (EV71). To date three vaccines against EV71 have been licensed in China, all using C4 genogroup strains. The efficacy of these three vaccines after two doses immunization ranges from 90.0% to 97.4% after one year of surveillance to 95.1% after two-year follow-up. Candidate vaccines containing B4 and B5 genogroups are in development elsewhere but have not yet reached the licensing stage. Other vaccines such as recombinant and other forms of subunit vaccines, vectored vaccines, virus-like particle vaccines are in the early stage of development. In addition, the development of vaccines against Coxsackie A16, A6 and A10 is being considered with a view to developing combination/multivalent vaccines

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Enterovirus Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enterovirus Vaccine.

The Enterovirus Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Enterovirus Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Enterovirus Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Enterovirus Vaccine Market Report

Report Metric	Details
Report Name	Enterovirus Vaccine Market
Accounted market size in year	US$ 362 million
Forecasted market size in 2031	US$ 534 million
CAGR	5.8%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Coxasckievirus A Coxasckievirus B Human Enterovirus 71 Others
Segment by Application	Hospital Research Institute Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology, Beijing Minhai Biotechnology
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Enterovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Enterovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Enterovirus Vaccine Market growing?

Ans: The Enterovirus Vaccine Market witnessing a CAGR of 5.8% during the forecast period 2025-2031.

What is the Enterovirus Vaccine Market size in 2031?

Ans: The Enterovirus Vaccine Market size in 2031 will be US$ 534 million.

Who are the main players in the Enterovirus Vaccine Market report?

Ans: The main players in the Enterovirus Vaccine Market are Sinovac Biotech, Medigen Vaccine Biologics, Shenzhen Neptunus, Sinopharm, Adimmune, Intravacc, Shanghai Zerun Biotechnology, Beijing Minhai Biotechnology

What are the Application segmentation covered in the Enterovirus Vaccine Market report?

Ans: The Applications covered in the Enterovirus Vaccine Market report are Hospital, Research Institute, Others

What are the Type segmentation covered in the Enterovirus Vaccine Market report?

Ans: The Types covered in the Enterovirus Vaccine Market report are Coxasckievirus A, Coxasckievirus B, Human Enterovirus 71, Others

Recommended Reports

Vaccine Market Landscape

Pediatric and Preventive Vaccines

Disease-specific Vaccines

1 Enterovirus Vaccine Market Overview

1.1 Product Definition

1.2 Enterovirus Vaccine by Type

1.2.1 Global Enterovirus Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Coxasckievirus A

1.2.3 Coxasckievirus B

1.2.4 Human Enterovirus 71

1.2.5 Others

1.3 Enterovirus Vaccine by Application

1.3.1 Global Enterovirus Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Hospital

1.3.3 Research Institute

1.3.4 Others

1.4 Global Enterovirus Vaccine Market Size Estimates and Forecasts

1.4.1 Global Enterovirus Vaccine Revenue 2020-2031

1.4.2 Global Enterovirus Vaccine Sales 2020-2031

1.4.3 Global Enterovirus Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Enterovirus Vaccine Market Competition by Manufacturers

2.1 Global Enterovirus Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Enterovirus Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Enterovirus Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Enterovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Enterovirus Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry

2.8 Global Enterovirus Vaccine Market Competitive Situation and Trends

2.8.1 Global Enterovirus Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Enterovirus Vaccine Players Market Share by Revenue

2.8.3 Global Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Enterovirus Vaccine Market Scenario by Region

3.1 Global Enterovirus Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Enterovirus Vaccine Sales by Region: 2020-2031

3.2.1 Global Enterovirus Vaccine Sales by Region: 2020-2025

3.2.2 Global Enterovirus Vaccine Sales by Region: 2026-2031

3.3 Global Enterovirus Vaccine Revenue by Region: 2020-2031

3.3.1 Global Enterovirus Vaccine Revenue by Region: 2020-2025

3.3.2 Global Enterovirus Vaccine Revenue by Region: 2026-2031

3.4 North America Enterovirus Vaccine Market Facts & Figures by Country

3.4.1 North America Enterovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Enterovirus Vaccine Sales by Country (2020-2031)

3.4.3 North America Enterovirus Vaccine Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Enterovirus Vaccine Market Facts & Figures by Country

3.5.1 Europe Enterovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Enterovirus Vaccine Sales by Country (2020-2031)

3.5.3 Europe Enterovirus Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Enterovirus Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Enterovirus Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Enterovirus Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Enterovirus Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Enterovirus Vaccine Market Facts & Figures by Country

3.7.1 Latin America Enterovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Enterovirus Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Enterovirus Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Enterovirus Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Enterovirus Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Enterovirus Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Enterovirus Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Enterovirus Vaccine Sales by Type (2020-2031)

4.1.1 Global Enterovirus Vaccine Sales by Type (2020-2025)

4.1.2 Global Enterovirus Vaccine Sales by Type (2026-2031)

4.1.3 Global Enterovirus Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Enterovirus Vaccine Revenue by Type (2020-2031)

4.2.1 Global Enterovirus Vaccine Revenue by Type (2020-2025)

4.2.2 Global Enterovirus Vaccine Revenue by Type (2026-2031)

4.2.3 Global Enterovirus Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Enterovirus Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Enterovirus Vaccine Sales by Application (2020-2031)

5.1.1 Global Enterovirus Vaccine Sales by Application (2020-2025)

5.1.2 Global Enterovirus Vaccine Sales by Application (2026-2031)

5.1.3 Global Enterovirus Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Enterovirus Vaccine Revenue by Application (2020-2031)

5.2.1 Global Enterovirus Vaccine Revenue by Application (2020-2025)

5.2.2 Global Enterovirus Vaccine Revenue by Application (2026-2031)

5.2.3 Global Enterovirus Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Enterovirus Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Sinovac Biotech

6.1.1 Sinovac Biotech Company Information

6.1.2 Sinovac Biotech Description and Business Overview

6.1.3 Sinovac Biotech Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Sinovac Biotech Enterovirus Vaccine Product Portfolio

6.1.5 Sinovac Biotech Recent Developments/Updates

6.2 Medigen Vaccine Biologics

6.2.1 Medigen Vaccine Biologics Company Information

6.2.2 Medigen Vaccine Biologics Description and Business Overview

6.2.3 Medigen Vaccine Biologics Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Medigen Vaccine Biologics Enterovirus Vaccine Product Portfolio

6.2.5 Medigen Vaccine Biologics Recent Developments/Updates

6.3 Shenzhen Neptunus

6.3.1 Shenzhen Neptunus Company Information

6.3.2 Shenzhen Neptunus Description and Business Overview

6.3.3 Shenzhen Neptunus Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shenzhen Neptunus Enterovirus Vaccine Product Portfolio

6.3.5 Shenzhen Neptunus Recent Developments/Updates

6.4 Sinopharm

6.4.1 Sinopharm Company Information

6.4.2 Sinopharm Description and Business Overview

6.4.3 Sinopharm Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sinopharm Enterovirus Vaccine Product Portfolio

6.4.5 Sinopharm Recent Developments/Updates

6.5 Adimmune

6.5.1 Adimmune Company Information

6.5.2 Adimmune Description and Business Overview

6.5.3 Adimmune Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Adimmune Enterovirus Vaccine Product Portfolio

6.5.5 Adimmune Recent Developments/Updates

6.6 Intravacc

6.6.1 Intravacc Company Information

6.6.2 Intravacc Description and Business Overview

6.6.3 Intravacc Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Intravacc Enterovirus Vaccine Product Portfolio

6.6.5 Intravacc Recent Developments/Updates

6.7 Shanghai Zerun Biotechnology

6.7.1 Shanghai Zerun Biotechnology Company Information

6.7.2 Shanghai Zerun Biotechnology Description and Business Overview

6.7.3 Shanghai Zerun Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Shanghai Zerun Biotechnology Enterovirus Vaccine Product Portfolio

6.7.5 Shanghai Zerun Biotechnology Recent Developments/Updates

6.8 Beijing Minhai Biotechnology

6.8.1 Beijing Minhai Biotechnology Company Information

6.8.2 Beijing Minhai Biotechnology Description and Business Overview

6.8.3 Beijing Minhai Biotechnology Enterovirus Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Beijing Minhai Biotechnology Enterovirus Vaccine Product Portfolio

6.8.5 Beijing Minhai Biotechnology Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Enterovirus Vaccine Industry Chain Analysis

7.2 Enterovirus Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Enterovirus Vaccine Production Mode & Process Analysis

7.4 Enterovirus Vaccine Sales and Marketing

7.4.1 Enterovirus Vaccine Sales Channels

7.4.2 Enterovirus Vaccine Distributors

7.5 Enterovirus Vaccine Customer Analysis

8 Enterovirus Vaccine Market Dynamics

8.1 Enterovirus Vaccine Industry Trends

8.2 Enterovirus Vaccine Market Drivers

8.3 Enterovirus Vaccine Market Challenges

8.4 Enterovirus Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

SINOVAC BIOTECH

Sinopharm

Adimmune

Intravacc

Beijing Minhai Biotechnology

Medigen Vaccine Biologics

Shenzhen Neptunus

Shanghai Zerun Biotechnology

List of Tables

Table 1. Global Enterovirus Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Enterovirus Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Enterovirus Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Enterovirus Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)

Table 5. Global Enterovirus Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Enterovirus Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Enterovirus Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Enterovirus Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Enterovirus Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Enterovirus Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Enterovirus Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Enterovirus Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Enterovirus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Enterovirus Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Enterovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Enterovirus Vaccine Sales by Region (2020-2025) & (K Doses)

Table 18. Global Enterovirus Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Enterovirus Vaccine Sales by Region (2026-2031) & (K Doses)

Table 20. Global Enterovirus Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Enterovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Enterovirus Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Enterovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Enterovirus Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Enterovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Enterovirus Vaccine Sales by Country (2020-2025) & (K Doses)

Table 27. North America Enterovirus Vaccine Sales by Country (2026-2031) & (K Doses)

Table 28. North America Enterovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Enterovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Enterovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Enterovirus Vaccine Sales by Country (2020-2025) & (K Doses)

Table 32. Europe Enterovirus Vaccine Sales by Country (2026-2031) & (K Doses)

Table 33. Europe Enterovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Enterovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Enterovirus Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Enterovirus Vaccine Sales by Region (2020-2025) & (K Doses)

Table 37. Asia Pacific Enterovirus Vaccine Sales by Region (2026-2031) & (K Doses)

Table 38. Asia Pacific Enterovirus Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Enterovirus Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Enterovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Enterovirus Vaccine Sales by Country (2020-2025) & (K Doses)

Table 42. Latin America Enterovirus Vaccine Sales by Country (2026-2031) & (K Doses)

Table 43. Latin America Enterovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Enterovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Enterovirus Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Enterovirus Vaccine Sales by Country (2020-2025) & (K Doses)

Table 47. Middle East and Africa Enterovirus Vaccine Sales by Country (2026-2031) & (K Doses)

Table 48. Middle East and Africa Enterovirus Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Enterovirus Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Enterovirus Vaccine Sales (K Doses) by Type (2020-2025)

Table 51. Global Enterovirus Vaccine Sales (K Doses) by Type (2026-2031)

Table 52. Global Enterovirus Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Enterovirus Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Enterovirus Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Enterovirus Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Enterovirus Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Enterovirus Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Enterovirus Vaccine Price (US$/Dose) by Type (2020-2025)

Table 59. Global Enterovirus Vaccine Price (US$/Dose) by Type (2026-2031)

Table 60. Global Enterovirus Vaccine Sales (K Doses) by Application (2020-2025)

Table 61. Global Enterovirus Vaccine Sales (K Doses) by Application (2026-2031)

Table 62. Global Enterovirus Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Enterovirus Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Enterovirus Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Enterovirus Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Enterovirus Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Enterovirus Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Enterovirus Vaccine Price (US$/Dose) by Application (2020-2025)

Table 69. Global Enterovirus Vaccine Price (US$/Dose) by Application (2026-2031)

Table 70. Sinovac Biotech Company Information

Table 71. Sinovac Biotech Description and Business Overview

Table 72. Sinovac Biotech Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 73. Sinovac Biotech Enterovirus Vaccine Product

Table 74. Sinovac Biotech Recent Developments/Updates

Table 75. Medigen Vaccine Biologics Company Information

Table 76. Medigen Vaccine Biologics Description and Business Overview

Table 77. Medigen Vaccine Biologics Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 78. Medigen Vaccine Biologics Enterovirus Vaccine Product

Table 79. Medigen Vaccine Biologics Recent Developments/Updates

Table 80. Shenzhen Neptunus Company Information

Table 81. Shenzhen Neptunus Description and Business Overview

Table 82. Shenzhen Neptunus Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 83. Shenzhen Neptunus Enterovirus Vaccine Product

Table 84. Shenzhen Neptunus Recent Developments/Updates

Table 85. Sinopharm Company Information

Table 86. Sinopharm Description and Business Overview

Table 87. Sinopharm Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 88. Sinopharm Enterovirus Vaccine Product

Table 89. Sinopharm Recent Developments/Updates

Table 90. Adimmune Company Information

Table 91. Adimmune Description and Business Overview

Table 92. Adimmune Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 93. Adimmune Enterovirus Vaccine Product

Table 94. Adimmune Recent Developments/Updates

Table 95. Intravacc Company Information

Table 96. Intravacc Description and Business Overview

Table 97. Intravacc Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 98. Intravacc Enterovirus Vaccine Product

Table 99. Intravacc Recent Developments/Updates

Table 100. Shanghai Zerun Biotechnology Company Information

Table 101. Shanghai Zerun Biotechnology Description and Business Overview

Table 102. Shanghai Zerun Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 103. Shanghai Zerun Biotechnology Enterovirus Vaccine Product

Table 104. Shanghai Zerun Biotechnology Recent Developments/Updates

Table 105. Beijing Minhai Biotechnology Company Information

Table 106. Beijing Minhai Biotechnology Description and Business Overview

Table 107. Beijing Minhai Biotechnology Enterovirus Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)

Table 108. Beijing Minhai Biotechnology Enterovirus Vaccine Product

Table 109. Beijing Minhai Biotechnology Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Enterovirus Vaccine Distributors List

Table 113. Enterovirus Vaccine Customers List

Table 114. Enterovirus Vaccine Market Trends

Table 115. Enterovirus Vaccine Market Drivers

Table 116. Enterovirus Vaccine Market Challenges

Table 117. Enterovirus Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Enterovirus Vaccine

Figure 2. Global Enterovirus Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Enterovirus Vaccine Market Share by Type: 2024 & 2031

Figure 4. Coxasckievirus A Product Picture

Figure 5. Coxasckievirus B Product Picture

Figure 6. Human Enterovirus 71 Product Picture

Figure 7. Others Product Picture

Figure 8. Global Enterovirus Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 9. Global Enterovirus Vaccine Market Share by Application: 2024 & 2031

Figure 10. Hospital

Figure 11. Research Institute

Figure 12. Others

Figure 13. Global Enterovirus Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 14. Global Enterovirus Vaccine Market Size (2020-2031) & (US$ Million)

Figure 15. Global Enterovirus Vaccine Sales (2020-2031) & (K Doses)

Figure 16. Global Enterovirus Vaccine Average Price (US$/Dose) & (2020-2031)

Figure 17. Enterovirus Vaccine Report Years Considered

Figure 18. Enterovirus Vaccine Sales Share by Manufacturers in 2024

Figure 19. Global Enterovirus Vaccine Revenue Share by Manufacturers in 2024

Figure 20. Global 5 and 10 Largest Enterovirus Vaccine Players: Market Share by Revenue in Enterovirus Vaccine in 2024

Figure 21. Enterovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 22. Global Enterovirus Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 23. North America Enterovirus Vaccine Sales Market Share by Country (2020-2031)

Figure 24. North America Enterovirus Vaccine Revenue Market Share by Country (2020-2031)

Figure 25. United States Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 26. Canada Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Europe Enterovirus Vaccine Sales Market Share by Country (2020-2031)

Figure 28. Europe Enterovirus Vaccine Revenue Market Share by Country (2020-2031)

Figure 29. Germany Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. France Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. U.K. Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Italy Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Russia Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Asia Pacific Enterovirus Vaccine Sales Market Share by Region (2020-2031)

Figure 35. Asia Pacific Enterovirus Vaccine Revenue Market Share by Region (2020-2031)

Figure 36. China Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Japan Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. South Korea Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. India Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Australia Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. China Taiwan Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Indonesia Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Thailand Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Malaysia Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Latin America Enterovirus Vaccine Sales Market Share by Country (2020-2031)

Figure 46. Latin America Enterovirus Vaccine Revenue Market Share by Country (2020-2031)

Figure 47. Mexico Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Brazil Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Argentina Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Middle East and Africa Enterovirus Vaccine Sales Market Share by Country (2020-2031)

Figure 51. Middle East and Africa Enterovirus Vaccine Revenue Market Share by Country (2020-2031)

Figure 52. Turkey Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. UAE Enterovirus Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Global Sales Market Share of Enterovirus Vaccine by Type (2020-2031)

Figure 56. Global Revenue Market Share of Enterovirus Vaccine by Type (2020-2031)

Figure 57. Global Enterovirus Vaccine Price (US$/Dose) by Type (2020-2031)

Figure 58. Global Sales Market Share of Enterovirus Vaccine by Application (2020-2031)

Figure 59. Global Revenue Market Share of Enterovirus Vaccine by Application (2020-2031)

Figure 60. Global Enterovirus Vaccine Price (US$/Dose) by Application (2020-2031)

Figure 61. Enterovirus Vaccine Value Chain

Figure 62. Channels of Distribution (Direct Vs Distribution)

Figure 63. Bottom-up and Top-down Approaches for This Report

Figure 64. Data Triangulation

Figure 65. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Foot and Mouth Disease Vaccines Market Research Report 2024

Enterovirus Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Foot and Mouth Disease FMD Vaccines Market Research Report 2025

Global Foot and Mouth Disease FMD Vaccination Market Research Report 2025

Global Molecular Diagnosis of Hand Foot and Mouth Disease Market Research Report 2024

Global Foot and Mouth Disease FMD Vaccines for Cattle Market Research Report 2025

Livestock Foot and Mouth Disease FMD Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Foot and Mouth Disease FMD Vaccines for Pig Market Research Report 2025

Coxsackievirus Infections Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Poliovirus Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Polio Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Poliomycetes Vaccine Market Insights Forecast to 2030

Cattle and Sheep Vaccine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enterovirus Testing Kit Market Insights Forecast to 2030

Bovine Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Oral Polio Vaccines OPV Market Research Report 2024

Global Animal Vaccines Market Insights Forecast to 2030

African Horse Sickness Vaccines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Enterovirus and Parechovirus Testing Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions